References
- Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353–68
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103–11
- Ruan X, Neubauer H, Yang Y, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 2012;15:467–72
- Chen FP, Chien MH, Chen HY, Ng YT. Effects of different progestogens on human breast tumor cell growth. Climacteric 2011;14:345–51
- Pompei LM, Steiner ML, Theodoro TR, et al. Effect of estrogen therapy on vascular perlecan and metalloproteinases 2 and 9 in castrated rats. Climacteric 2013;16:147–53
- Pompei LM, Carvalho FM, Ortiz SC, Motta MC, Cruz RJ, Melo NR. Morphometric evaluation of effects of two sex steroids on mammary gland of female rats. Maturitas 2005;51:370–9
- Wood CE, Branstetter D, Jacob AP, et al. Progestin effects on cell proliferation pathways in the postmenopausal mammary gland. Breast Cancer Res 2013;15:R62
- Cline JM, Register TC, Clarkson TB. Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys. Menopause 2002;9:422–9
- Conner P, Register TC, Skoog L, et al. Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. Am J Obstet Gynecol 2005; 193:58–63
- Cummings SR, Ettinger B, Delmas PD, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008; 359:697–708
- Kenemans P, Bundred NJ, Foidart JM, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009;10:135–46
- Wren BG. The origin of breast cancer. Menopause 2007;14: 1060–8
- Jezierska-Drutel A, Rosenzweig SA, Neumann CA. Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 2013;119: 107–25